Contents

Search


neonatal screening

Procedure: - standard protocol to screen for: - congenital hypothyroidism - phenylketonuria (PKU) - other screening may include screening for: - galactosemia - sickle cell disease - biotinidase deficiency - congenital adrenal hyperplasia - maple syrup urine disease - homocystinuria - tyrosinemia - cystic fibrosis - toxoplasmosis - hearing impairment - pulse oximetry for congenital heart defects [1,2]* * Only Idaho & Wyoming do not have mandatory screening

Related

neonatal (newborn) newborn screening panel

Specific

amino acidemia newborn screen beta-galactosidase blood spot branched chain keto-acid dehydrogenase complex in blood citrulline/arginine in dried blood spot citrulline/phenylalanine in dried blood spot citrulline/tyrosine in dried blood spot creatine kinase MM in blood; GSP Neonatal Creatine Kinase-MM kit endocrine disorder newborn screen fatty acid oxidation defects newborn screen galactose in blood spot galactosemia newborn screen hemoglobin disorders newborn screen hemolytic disease of the newborn screen lysosomal storage disorder screeing (Seeker system) medium/short chain acyl-CoA dehydrogenase deficiency newborn screen monolysocardiolipin/Cardiolipin in dried blood spot organic acids newborn screen phenylalanine in dried blood spot phenylalanine/tyrosine in blood screening for cystic fibrosis screening for galactosemia screening for phenylketonuria T-cell receptor excision circle in dried blood spot thyrotropin (TSH) in blood spot thyroxine (T4) in dried blood spot tyrosine in dried blood spot tyrosine/phenylalanine in blood

General

screening

References

  1. Thangaratinam S et al Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis The Lancet, Early Online Publication, 2 May 2012 PMID: 22554860 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60107-X/fulltext - Centers for Disease Control and Prevention Protocol. Methods and Screening Algorithm. Screening for Critical Congenital Heart Defects http://www.cdc.gov/ncbddd/pediatricgenetics/pulse.html
  2. Abouk R, Grosse SD, Ailes EC, Oster ME. Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths. JAMA. 2017;318(21):2111-2118. PMID: 29209720 https://jamanetwork.com/journals/jama/article-abstract/2664999 - Kemper AR, Lam WKK, Bocchini JA Jr The Success of State Newborn Screening Policies for Critical Congenital Heart Disease. JAMA. 2017;318(21):2087-2088. PMID: 29209703 https://jamanetwork.com/journals/jama/article-abstract/2664979
  3. Kid's Health http://kidshealth.org/parent/system/medical/newborn_screening_tests.html

Components

17-hydroxyprogesterone in blood biotinidase in blood